https://www.massdevice.com/edwards-plans-to-spin-off-critical-care-business-next-year/
Link to Edwards future plans. The following bit looks interesting -
"Edwards anticipates CE mark for its Sapien M3 TMTT device by the end of 2025. It plans to complete early enrollment in an aortic stenosis treatment trial in early 2024. The company expects EARLY TAVR data studying aortic stenosis patients at TCT 2024."
Further Update on Edwards
-
- There are more pages in this discussion • 200 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.60 |
Change
-0.100(0.53%) |
Mkt cap ! $357.5M | |||
| Open | High | Low | Value | Volume |
| $18.70 | $18.77 | $18.21 | $664.1K | 35.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $18.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.69 | 53 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |